📰 Genentech News
Page 89 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
October 19, 2023
David S. Hong, MD, and David Sommerhalder, MD, discuss the unmet needs for patients with KRAS G12C–mutant non–small cell lung cancer (NSCLC) and colorectal cancer (CRC) that prompted the initiation of the RMC-6291-001 trial; the key efficacy and safety findings with RMC-6291 in patients with NSCLC and CRC; and potential next steps for this agent.
October 18, 2023
Genentech, Inc., affiliated to Swiss drug major Roche Holding AG (RHHBY), announced Wednesday results from the primary analysis of the Phase III ALINA study of Alecensa (alectinib) in people with anaplastic lymphoma kinase or ALK-positive non-small cell lung cancer or NSCLC.
October 18, 2023
Neonatal sepsis is a leading cause of death for newbornsTesting IL-6 can indicate a neonatal sepsis infection earlier than other biomarkersEarlier diagnosis of neonatal sepsis can lead to improved...
October 18, 2023
18.10.2023 - Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from the primary analysis of the Phase III ALINA study demonstrating a statistically significant and clinically meaningful improvement in disease-free ... Seite 1
October 18, 2023
WILLIAMSBURG — The 14th annual Run for the Hills event, sponsored by Here For The Girls (H4TG), was held in New Town on Oct. 7 and raised more than $40,000…
October 18, 2023
/PRNewswire/ -- Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal...
October 18, 2023
/PRNewswire/ -- The "DNA Encoded Library: Platforms and Services Market (2nd Edition), 2023-2035" report has been added to ResearchAndMarkets.coms offering....
October 17, 2023
Mr. Garland brings significant industry expertise with a long track record of successful launchesSAN FRANCISCO, Oct. 17, 2023 -- Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical...
October 17, 2023
/PRNewswire/ -- The "US Bispecific Antibodies Market & Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.coms offering. The...